Clinical Trials Logo
  1. Home
  2. Stress Disorders, Posttraumatic
  3. NCT00674570

Veteran Stress and Learning Study — VSL  

Stress Disorders, Posttraumatic Clinical Trial

Official title:
Effects of Hydrocortisone and D-Cycloserine on Fear Extinction in Veterans With Posttraumatic Stress Disorder

Clinical Trial Summary

This is a research study examining the use of two medications, Hydrocortisone and D-Cycloserine, compared to an inactive substance (placebo), on their ability to reduce fear responses and memory of fear in Veterans with symptoms of Posttraumatic Stress Disorder (PTSD). These responses will be tested using a fear learning and memory task administered by computer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00674570
Study type Interventional
Source VA Office of Research and Development
Contact
Status Completed
Phase Phase 4
Start date January 13, 2009
Completion date June 22, 2015
View Details
See also
  Status Clinical Trial Phase
Completed NCT00625131 - Nicotine Patch Pretreatment for Smoking Cessation in PTSD Phase 0
Completed NCT00373698 - Re-Engineering Systems for the Primary Care Treatment for PTSD Phase 3
Recruiting NCT04651296 - Compassion Meditation vs. Health Education for Veterans Phase 2
Completed NCT02226367 - Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD N/A
Completed NCT01058031 - Neural Correlates of PTSD Prevention With Mindfulness Based Stress Reduction (MBSR) in Iraqi Veterans N/A
Recruiting NCT03642028 - Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress Phase 4
Completed NCT04002050 - Creating Resilient Workplaces Study N/A
Completed NCT00451282 - Stepped Preventive Care to Reduce the Impact of Acute Pediatric Injury Phase 3